Advances with microRNAs in Parkinson’s disease research

Parkinson’s disease (PD) is the second-most common age-dependent neurodegenerative disorder and is caused by severe degeneration of dopaminergic neurons in the substantia nigra pars compacta. Unfortunately, current treatment only targets symptoms and involves dopamine replacement therapy, which does...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Liuqing, Wei, Liangming, Wu, Fei, Hu, Zhenhua, Liu, Zhenguo, Yuan, Weien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792848/
https://www.ncbi.nlm.nih.gov/pubmed/24109179
http://dx.doi.org/10.2147/DDDT.S48500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792848/
https://www.ncbi.nlm.nih.gov/pubmed/24109179
http://dx.doi.org/10.2147/DDDT.S48500

Ejemplares similares